Answers are grounded in this paper and cite their sources.
European health systems are facing increasing pressure from demographic change and economic constraints. Yet, they are also coming under growing scrutiny for their environmental impact, as they are responsible for over 5% of national CO2 emissions, with pharmaceuticals accounting for 12% of this footprint.1 While significant attention has rightly been paid to the ecological impact of pharmaceutical manufacturing, the end-of-life stage of medicines remains far less addressed. As a result, the disposal of unused or expired medications remains a largely overlooked blind spot–with serious implications for environmental sustainability, public safety, and health system efficiency.
No takes yet. Share an insight, caveat, or question.
Kardas et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: